Related Experiment Video
Updated: Aug 9, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis
Antônio da Silva Menezes Junior1,2, Lara Cristina Ferreira1, Laura Júlia Valentim Barbosa1
1Internal Medicine Department, Cardiology and Genetic Section, Pontifical Catholic University of Goiás, Goiânia 74175-120, GO, Brazil.
Abstract:
Atrial fibrillation (AF) is the most frequently occurring supraventricular arrhythmia. Although microRNAs (miRNAs) have been associated with AF pathogenesis, standard protocols for quantifying and selecting specific miRNAs for clinical use as biomarkers should be optimized. In this study, we evaluated the clinical application of miRNAs as biomarkers for the prognosis and diagnosis of AF. Literature searches were conducted on PubMed, Cochrane Library, and EMBASE. We included prospective or retrospective observational studies that had been published as of 14 February 2022; our main objective was to analyze the relationship between circulating miRNAs and AF. The data were extracted using the descriptors "Atrial fibrillation AND miRNA", "Atrial fibrillation AND diagnostic AND miRNA", and "Atrial fibrillation AND prognosis AND miRNA". No filters were applied for period delimitation, type of publication, or language. Studies using samples isolated from blood plasma and TaqMan and RT-qPCR for detecting and quantifying miRNAs were selected, and those that used atrial tissue samples were excluded. We identified 272 articles and excluded 102 duplicated articles. Two authors independently read the titles and abstracts of 170 out of 272 articles and selected 56 potential articles, 6 of which were selected for final review. Our analysis revealed a significant association between AF and miR-4798 [OR = 1.90 (95% CI 1.45-2.47)], AF and miRNA-133a [2.77 (2.73-2.82)], AF and miRNA-150 [3.77 (1.50-9.46); I2 = 70%], AF and miRNA-21 [2.23 (1.20-4.17); I2 = 99%], AF and hsa-miRNA4443 [2.32 (2.20-2.44)], and AF and miR-20a-5p [3.67 (1.42-9.49)]. The association between miRNAs and AF showed an OR of 2.51 [95% CI 1.99-3.16; I2 = 99%]. Our meta-analysis demonstrated that circulating miRNAs are potential biomarkers of AF, as they exhibit stable expression post-sample collection. In addition to regulating cellular processes, such as proliferation, differentiation, development, and cell death, miRNAs were found to be linked to arrhythmia development.
Insights
Circulating microRNAs (miRNAs) show significant associations with atrial fibrillation (AF), indicating their potential as diagnostic and prognostic biomarkers. This meta-analysis confirms miRNAs
Area of Science:
- Biochemistry and Molecular Biology
- Cardiology
- Genetics
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia with complex pathogenesis.
- MicroRNAs (miRNAs) are implicated in AF development, but standardized biomarker protocols are lacking.
- Optimizing miRNA quantification is crucial for clinical application in AF diagnosis and prognosis.
Purpose of the Study:
- To evaluate the clinical utility of circulating miRNAs as biomarkers for atrial fibrillation (AF) prognosis and diagnosis.
- To analyze the association between circulating miRNAs and AF through a systematic literature review and meta-analysis.
Main Methods:
- Conducted literature searches on PubMed, Cochrane Library, and EMBASE for observational studies on circulating miRNAs and AF.
- Selected studies using blood plasma samples and RT-qPCR for miRNA detection, excluding atrial tissue samples.
- Performed a meta-analysis on 6 selected studies, extracting data on specific miRNAs and their association with AF.
Main Results:
- Identified significant associations between AF and specific miRNAs: miR-4798, miRNA-133a, miRNA-150, miRNA-21, hsa-miRNA4443, and miR-20a-5p.
- The overall meta-analysis showed a combined odds ratio (OR) of 2.51 (95% CI 1.99-3.16) for the association between circulating miRNAs and AF.
- Circulating miRNAs demonstrated stable expression post-sample collection, supporting their biomarker potential.
Conclusions:
- Circulating miRNAs are promising biomarkers for the diagnosis and prognosis of atrial fibrillation.
- Specific miRNAs, including miR-4798, miRNA-133a, miRNA-150, miRNA-21, hsa-miRNA4443, and miR-20a-5p, are significantly associated with AF.
- Further optimization of miRNA quantification protocols is needed for widespread clinical adoption.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
09:48Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
Published on: July 27, 2016